Oxford Biomedica Share Discussion Threads

[gigabit] 03/11/2022 16:38

#469 - the situation you describe cannot happen. Homology's option can be exercised at any time after 3 years from the agreement date, in perpetuity as no end date is specified. So to prevent that situation OXB would need to permanently turn down work which is hardly a good business model. It's just one aspect among many that makes this such an awful deal.

#470 - given the performance of the OXB management I doubt that it is likely but if they have it should be apparent in the year end accounts.

[marcusl2] 03/11/2022 14:30

Just while things are quiet, super results here;


Whatever happened to OXB`s NK program ?

[steeplejack] 03/11/2022 12:30

This won't help sentiment surrounding OXB today.Shares of Moderna (NASDAQ: MRNA) plunged in pre-market trading on Thursday as the messenger RNA (mRNA) biotechnology company's Q3 earnings missed estimates. The company posted revenues of $3.4 billion, a drop of 32% year-over-year, missing Street estimates by $170 million. The fall in revenues was mainly due to a decline in sales of its COVID-19 vaccines. Diluted earnings came in at $2.53 per share, a drop of 67%, again falling short of analysts' estimates of $3.3. Stéphane Bancel, Moderna's CEO stated, "Today's earnings continue to show strong corporate momentum.

[squidsgone] 03/11/2022 12:00

Likely $74m would have been hedged at the time the likely obligation arose.

[stocktastic] 03/11/2022 10:01

Yes, I would align with you.

That would mean in GBP terms, the cap at present is more like £65m

To hit that though would mean Homology having at least a good year of business

I'm thinking that worst case for OXB is if Homology gets a one off type of contract on not brilliant margin. OXB the has to pay full cap for business that is neither recurring nor valuable.
... although OXB has a say in what business is taken on
Do I have that right.

[marcusl2] 02/11/2022 22:17

Posting in case anyone knows someone with Breast, Head and Neck, Ovarian, or Renal Cancer

Encouraging for people hoping to get on the Modi trial.

[campoverde] 02/11/2022 15:39

please do not buy anymore or we will be in the twos.

[gigabit] 02/11/2022 15:12

They could hold off if the prospects for the Boston unit looked promising at that time. But that assumes that they have the cash to continue operating themselves and that would necessarily involve a fund-raise given their ongoing cash burn. For that reason holding off seems unlikely. It would be nice to be wrong as that would mean that the Boston unit had become very profitable.

With regard to the cap the statement said 'In addition, the maximum purchase price payable by Oxford Biomedica US or Oxford Biomedica Solutions on exercise of the Call Option or the Put Option will be capped at US$74.1 million (GBP55.4 million).' So you can take your pick as to which is the actual figure. I would guess the $ transaction and they converted using the exchange rate at the time of the statement.

[stocktastic] 02/11/2022 14:54

"Homology is a cash burner and, by its own admission, will continue to be so. There is therefore no possibility that the option will not be exercised"

Gigabit
They could in theory hold off the put option in the hope of getting morr for the shares at a later date??


"will be capped at US$74.1 million (GBP55.4 million)"

Is it capped at £55m
Or is it capped at $74m.... and that just equated to £55m at the time.
Not clear to me if both figures are the cap or just USD?

[marcusl2] 02/11/2022 10:11

We're thrilled to welcome Kyriacos Mitrophanous, PhD, Chief Scientific Officer at
@OxfordBioMedica
, as a featured speaker in the #ViralVectors & #Vaccines program at our 12th Spring Meeting! For event details and additional speakers, visit: #biotech

[dominiccummings] 02/11/2022 07:45

Enough foreign comments!

[gareth jones] 01/11/2022 23:41

Amser a ddengys!

[marcusl2] 01/11/2022 21:16

Albanian (Time reveals all things)

[dominiccummings] 01/11/2022 20:54

I think you've got us there Marcus

[marcusl2] 01/11/2022 20:44

Gareth, the way things are going you need to catch up with modern Britain my friend.

Koha zbulon të gjitha gjërat

[mr_mike1] 01/11/2022 20:10

The trouble is that with OXB tempus doesn't fugit.

[dominiccummings] 01/11/2022 18:51

Aye Gareth, we will see.

[gareth jones] 01/11/2022 17:06

Tempus omnia revelat. Looks a little more positive lately,

[catch007] 01/11/2022 16:46

The only hint of rumour is on the BB not seen anything else to substantiate anything and the price has steadied.

[marcusl2] 01/11/2022 14:48

Now you`ve done it. We are dropping again.

[dominiccummings] 01/11/2022 13:33

Significant rise so far today. Bid rumours or Marcusl2 buying?

[marcusl2] 01/11/2022 10:59

I am here. Bought a very small amount last week just in case the rumour is true ;-)

[badger60] 01/11/2022 09:51

Love it!! Cummings is not sure if his thread is working.......much like OXB.......

[dominiccummings] 01/11/2022 09:38

Not sure the thread is working. This is a test.